Regeneron Pharmaceuticals

An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 39 trials in this atlas.

  • Organization
  • In this atlas

Overview

Technical summary

Sponsor class industry. No ROR record matches the name exactly.

Trials at a glance

These figures count only the registry trials in this atlas that name Regeneron Pharmaceuticals as a sponsor: 39 trials, 19 as lead sponsor and 20 as collaborator.

Phase and status

Trials by phase and registry status
PhaseRecruitingNot yet recruitingActive, not recruitingCompletedAll statuses
Phase 220147
Phase 2/300011
Phase 37102028
Phase 400033
All phases9112839

Start year

Trials started per year
Start yearTrials
20268
20252
20232
20201
20182
20171
20164
20154
20141
20134
20129
20111

Main countries

  • United States 30 trials
  • Canada 20 trials
  • France 13 trials
  • Japan 13 trials
  • United Kingdom 13 trials

Roles

  • Company
  • Sponsor

Sector

Industry

The registry's words

Labels as the registry gives them, not rewritten.

Sponsor name
Regeneron Pharmaceuticals
Sponsor class
INDUSTRY

Registry records

Assembled by a program from ClinicalTrials.gov. No person wrote or checked these pages, and they are counted apart from the pages that people wrote. Lists of trials come from the registry's own coding and may miss trials.

Registry trials 39

Record details

Record id
cardio:org-regeneron-pharmaceuticals
Content hash
cd486243adae1c4cd986d8713748d12d754bae0ccd9a863fd1b4e62af63e4224